Investigator

Johanna A. van der Zande

PhD candidate · Erasmus University Rotterdam, Cardiology

JAVJohanna A. van de…
Papers(1)
Recurrent postmenopau…
Collaborators(4)
Laura D. P. R. van Ma…Patricia C. Ewing‐Gra…Bernadette A. M. Heem…Helena C. van Doorn
Institutions(2)
Erasmus McErasmus MC Cancer Ins…

Papers

Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study

AbstractIntroductionRecurrent postmenopausal bleeding (PMB) occurs in 6%–25% of postmenopausal women who have experienced a previous episode of PMB. The question of whether recurrent PMB leads to a higher risk of endometrial cancer (EC) in comparison to a single episode of PMB is, however, controversial. Furthermore, little is known about predictive factors for recurrent PMB.Material and MethodsA multicenter prospective cohort study was conducted over a 5‐year period in four hospitals in the Netherlands. Women with PMB undergoing endometrial sampling and aged 40 years and older were included. Occurrence of recurrent PMB was retrospectively determined. Primary outcomes included (1) the incidence of recurrent PMB and (2) differences in pathological findings between patients with a single episode vs recurrent PMB. Secondary outcomes included (1) the association between diagnosis of benign polyps at first PMB and pathological findings at recurrent PMB and (2) factors predictive for recurrent PMB.ResultsA total of 437 women with PMB were included, of whom 360 were at risk of recurrent PMB. With a median follow‐up of 61 months (IQR (Interquartile range) 44–73), 26.4% experienced recurrent PMB. Patients with recurrent PMB were more often diagnosed with benign polyps (34.7% vs. 25.1%, p‐value 0.015) and less frequently with a malignancy (5.3% vs. 17.8%, p‐value 0.015), compared to patients with a single episode of PMB. Benign polyps at initial PMB were not associated with a (pre)malignancy at recurrence (OR 4.16, 95% CI 0.75–23.03). Predictive factors for recurrent PMB included use of hormone replacement therapy (HRT) (OR 3.32, 95% CI 1.64–6.72), and benign polyps at initial PMB (OR 1.80, 95% CI 1.07–3.04).ConclusionsRecurrent PMB is common in women with a previous episode of PMB. Compared to patients with a single episode of PMB, patients with recurrent PMB and benign histological outcomes at accurate workup during their first episode were less often diagnosed with malignancies and more frequently with benign polyps. Benign polyps at first PMB are predictive for recurrent PMB, but not for a higher risk of (pre)malignancy.

19Works
1Papers
4Collaborators

Positions

2026–

PhD candidate

Erasmus University Rotterdam · Cardiology

2025–

PhD candidate

Erasmus University Rotterdam · Cardiology

2025–

Researcher

Erasmus University Rotterdam · Cardiology

2025–

PhD candidate

Erasmus University Rotterdam · Cardiology

2025–

PhD candidate

Erasmus University Rotterdam · Cardiology

2024–

PhD candidate

Erasmus University Rotterdam · Cardiology

2024–

PhD candidate

Erasmus University Rotterdam · Cardiology

2024–

PhD candidate

Erasmus University Rotterdam · Cardiology

2023–

PhD candidate

Erasmus University Rotterdam · Cardiology

2023–

PhD candidate

Erasmus University Rotterdam · Cardiology

2021–

PhD candidate

Erasmus University Rotterdam · Obstetrics & Gynecology

2021–

PhD candidate

Erasmus University Rotterdam · Obstetrics & Gynecology